Insights into Transthyretin Variants and Cardiac Outcomes

This chapter explores a comprehensive study on transthyretin (TTR) variants, focusing on their impact on cardiac health and mortality. It highlights the need for improved disease phenotyping and effective population screening strategies for hereditary amyloidosis. The chapter reveals significant findings from a large biobank, detailing the methodologies used and calling attention to the importance of equitable access to screening for at-risk populations.